Skip to content

KATALYST Life Sciences: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

KATALYST Life Sciences

BE 0760.501.477
NACE 72.101, Research and development on biotechnology
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€6,729
2024 · €53,914-€60,643
Equity
€317,784
2024 · €324,513-€6,729
Cash
€68,146
2024 · €337,497-€269,352
Balance sheet total
€320,875
2024 · €377,246-€56,371

Largest movements

2024 to 2025
Assets
  • Cash -€269,352

    down €269,352 (-79.8%), from €337,497 to €68,146

    mainly Current investments (-€239,718) and Other debts (-€44,475)

  • Current investments +€239,718

    new in 2025: €239,718

  • Receivables within one year -€27,441

    down €27,441 (-85.3%), from €32,156 to €4,715

    of which Other amounts receivable: -€23,438

Equity and liabilities
  • Other debts -€44,475

    down €44,475 (-98.8%), from €45,000 to €525

  • Profit (loss) carried forward -€6,729

    down €6,729 (-75.5%), from €8,914 to €2,185

Income statement
  • Gross operating margin -€71,952

    down €71,952, from €67,096 to -€4,856

  • Taxes -€7,750

    down €7,750 (-95.2%), from €8,138 to €388

  • Financial income +€3,087

    up €3,087 (+1828.6%), from €169 to €3,256

  • Depreciation -€1,522

    down €1,522 (-40.7%), from €3,743 to €2,221

  • Financial charges +€1,405

    up €1,405 (+748.5%), from €188 to €1,592

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €53,914
Gross operating margin -€71,952
Depreciation +€1,522
Other operating charges +€355
Financial income +€3,087
Financial charges -€1,405
Taxes +€7,750
Result 2025 -€6,729

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€28,434
Investment -€240,918
Financing €0
Cash 2024 €337,497
Net result for the year -€6,729
Depreciation +€2,221
Receivables within one year +€27,441
Deferred charges and accrued income -€1,725
Trade debts -€1,451
Tax, wage and social debts -€3,716
Other debts -€44,475
Investment in fixed assets (net) -€1,200
Current investments -€239,718
Cash 2025 €68,146
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €377,246 €320,875 -€56,371 -14.9%
Fixed assets 21/28 €7,248 €6,227 -€1,021 -14.1%
Tangible fixed assets 22/27 €7,248 €6,227 -€1,021 -14.1%
Furniture and vehicles 24 €7,248 €6,227 -€1,021 -14.1%
Current assets 29/58 €369,997 €314,648 -€55,350 -15.0%
Amounts receivable within one year 40/41 €32,156 €4,715 -€27,441 -85.3%
Trade receivables 40 €4,002 €0 -€4,002 -100.0%
Other amounts receivable 41 €28,154 €4,715 -€23,438 -83.3%
Current investments 50/53 - €239,718 +€239,718
Cash at bank and in hand 54/58 €337,497 €68,146 -€269,352 -79.8%
Deferred charges and accrued income 490/1 €344 €2,069 +€1,725 +501.2%
Total equity and liabilities 10/49 €377,246 €320,875 -€56,371 -14.9%
Equity 10/15 €324,513 €317,784 -€6,729 -2.1%
Contributions 10/11 €3,000 €3,000 = 0.0%
Reserves 13 €312,599 €312,599 = 0.0%
Distributable reserves 133 €312,599 €312,599 = 0.0%
Profit (loss) carried forward 14 €8,914 €2,185 -€6,729 -75.5%
Amounts payable 17/49 €52,733 €3,091 -€49,642 -94.1%
Amounts payable within one year 42/48 €52,733 €3,091 -€49,642 -94.1%
Trade debts 44 €3,698 €2,247 -€1,451 -39.2%
Suppliers 440/4 €3,698 €2,247 -€1,451 -39.2%
Taxes, remuneration and social security 45 €4,035 €319 -€3,716 -92.1%
Taxes 450/3 €4,035 €319 -€3,716 -92.1%
Other amounts payable 47/48 €45,000 €525 -€44,475 -98.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,743 €2,221 -€1,522 -40.7%
Other operating charges 640/8 €1,283 €928 -€355 -27.7%
Gross operating margin 9900 €67,096 -€4,856 -€71,952
Operating profit (loss) 9901 €62,071 -€8,005 -€70,076
Financial income 75/76B €169 €3,256 +€3,087 +1828.6%
Recurring financial income 75 €169 €3,256 +€3,087 +1828.6%
Financial charges 65/66B €188 €1,592 +€1,405 +748.5%
Recurring financial charges 65 €188 €1,592 +€1,405 +748.5%
Profit (loss) for the period before taxes 9903 €62,052 -€6,341 -€68,393
Income taxes 67/77 €8,138 €388 -€7,750 -95.2%
Profit (loss) for the period 9904 €53,914 -€6,729 -€60,643
Profit (loss) for the period to be appropriated 9905 €53,914 -€6,729 -€60,643

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.